2018 Translational Research Grant

Number of applications Fred Hutch/UW Cancer Consortium may submit: one nominee. The foundation encourages research on the biological basis of cancer disparities experienced by patients from minority ethnic or racial populations in areas related to causes, aggressiveness, treatment or relapse. Cancers in which ethnic and racial disparities have previously been demonstrated include: lung and bronchus, colon and rectum, breast, prostate, uterine, cervix, stomach and liver.

Synopsis:

The V Foundation for Cancer Research seeks to support translational research projects within the scope of all types of cancers.

Definition of a translational research project: Translational projects should move a novel strategy from the laboratory into a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms. The research should apply in some direct way to human beings within the time frame of less than 3 years. If biomarker research is undertaken, a validation set or independent clinical trial is essential. A plan for biomarker validation, if applicable, must be included in any proposal. The endpoint of the project should be the planning or initiation of a new clinical trial.

Eligibility: 

The nominated applicant must be the lead Principal Investigator (PI) on the Translational Award research team. The applicant must meet all of the following criteria to be eligible to submit an application:

• The nominee must be nominated by their Cancer Center Director if the research institution is a cancer center. If the research institution is not a cancer center, then the provost, dean or other senior research administrative official who is responsible for the internal nominee selection process may make the nomination. We do not review unsolicited applications.
• Applicant must be employed at a non-profit research institution (e.g. 501c3, Section 170).
• By the Due Date of the Application, the applicant who will lead the research team must have all the following:
• Be a scientist in a tenure-track faculty position at their cancer research institution. Non-promotable, adjunct, affiliated, temporary, part-time or acting faculty positions are not eligible for Principal Investigator nomination to lead the Translational Research Team.
• Applicants must be either a US or Canadian Citizen, or have a legal permit to work in the USA (either temporary or permanent).

Funding:

• $600,000 total paid in three annual installments of $200,000/year.
• A maximum of 10% of the grant may be used annually to offset the indirect costs of the project.
• This award is not listed on Exhibit A. The endorsed applicant must have Fred Hutch Director’s Office approval for unrecovered F&A costs before submitting an application, and should work with their Division Administrator to complete this task.

Application Instructions

Internal Pre-Proposal Deadline:  Monday, April 9^th, 2018

Interested and eligible investigators should submit a single PDF of the required pre-proposal materials (see attached) to fundinginfo@fredhutch.org by the internal deadline to be considered by the Fred Hutch’s Internal Awards Committee. 

Deadline for Naming (IAC) Endorsed Nominees to Foundation:  Monday, March 16^th by 2:00 pm PT

Funding Agency Application Deadline:  Wednesday, May 30^th, 2018  

The selected Fred Hutch candidate may be assisted by Institutional Giving with preparing their application for submission.

For additional information, including eligibility guidelines and the required pre-proposal schedule and materials, please see the attached funding announcement.

Questions may be directed to fundinginfo@fredhutch.org.